Fig. 6 | British Journal of Cancer

Fig. 6

From: STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer

Fig. 6

STING agonist enhances response to chemotherapy in a mouse model of HGSC. Kaplan–Meier survival analysis showing significantly increased survival of mice treated with carboplatin + STING agonist + anti-PD-1 or carboplatin + STING agonist combination compared to carboplatin only, STING agonist only and vehicle-treated mice. Log-rank (Mantel Cox) test was applied to derive significant differences (p < 0.05) in survival between different treatment groups (Table). For each treatment arm, 6–8 mice were included

Back to article page